Investor mix
3 investors on record; lead investors include Limousin Participations.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Private equity | 2 | 67% |
Provider of a diagnostic test for the personalization of cancer treatment
3 investors on record; lead investors include Limousin Participations.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Private equity | 2 | 67% |